Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy for Superficial Basal Cell Carcinoma Comparing HAL, BF-200 ALA, and MAL
NCT02367547Phase 2Active, not recruiting
- Sponsor
- Päijät-Häme Wellbeing Services County
- Start
- Mar 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hexaminolevulinate, aminolevulinic acid 10% gel in basal cell carcinoma (BCC), sponsored by Päijät-Häme Wellbeing Services County. Started Mar 2015; status: active, not recruiting.
02
Drugs
hexaminolevulinateaminolevulinic acid 10% gel
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02367547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367547.